Singapore markets closed
Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
56,586.95 +2,257.69 (+4.16%) CMC Crypto 200
1,178.58 -30.11 (-2.49%)
PTCT Sep 2024 33.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 04:48PM EDT
| Previous close | 2.8000 |
| Open | N/A |
| Bid | 4.6000 |
| Ask | 8.4000 |
| Strike | 33.00 |
| Expiry date | 2024-09-20 |
| Day's range | 2.8000 - 2.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
ZacksPTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) falls as the EC's advisory committee adopts a negative opinion regarding the renewal of the conditional marketing approval of Translarna to treat nmDMD in the EU.
PR NewswireCHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the CHMP has issued a negative opinion on the renewal of the conditional marketing authorization of Translarna™ (ataluren) for the treatment of nmDMD. This opinion follows the return of the previously issued negative opinion by the European Commission (EC) for re-review.
ZacksPTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
© 2024 Yahoo. All rights reserved.